Masimo Corporation (MASI) Revenue by Segment
Masimo revenue by segment at a glance
In Q3 fiscal 2023 (the quarter ended September 30, 2023), Masimo's largest business segment was Health Care, with $307.80 million or 64% of revenue, down 5.9% from a year earlier. Next: Non-Healthcare (36%).
The fastest-growing business segment from a year earlier was Health Care (-5.9%).
From company filings, in USD; latest quarter ended September 30, 2023; quarterly data from Q2 fiscal 2021.
Masimo Corporation
MASI
Healthcare
Revenue breakdown
Fiscal quarters, from company filings
Masimo revenue by business segment, last 4 quarters
| Business segment | Q1 FY26 | Q3 FY25 | Q2 FY25 | Q1 FY25 | Share |
|---|---|---|---|---|---|
| Health Care | $402.6M | $371.2M | $370.3M | $371.0M | 64% |
| Non-Healthcare | – | – | – | – | 36% |
In USD, fiscal quarters as reported; share = part of Q3 FY23 revenue.
Questions and answers
What are Masimo's business segments?
Health Care and Non-Healthcare (as reported for Q3 fiscal 2023).
Which business segment makes the most money for Masimo?
Health Care: $307.80 million, or 64% of revenue, in Q3 fiscal 2023.
RelatedElectromedical and Electrotherapeutic Apparatus Manufacturing industryManufacturing sectorShanghai MicroPort Endovascular MedTech (688016.SS)Kubota Pharmaceutical Holdings (4596.T)Glaukos revenue by segmentAutek China (300595.SZ)Dynavox Group AB (publ) (DYVOX.ST)Eyebright Medical Technology (Beijing) (688050.SS)
Disclaimer: This analysis is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice. Data may be incomplete, delayed, or contain inaccuracies. Consult with a qualified financial advisor before making any investment decisions.
